Inventor
GOTSCHALL RUSSELL
US15 patents
Patents
15 patentsUS10208299B2Feb 19, 2019
Highly potent acid alpha-glucosidase with enhanced carbohydrates
AMICUS THERAPEUTICS INC12 citations92
US10961522B2Mar 30, 2021
Highly potent acid alpha-glucosidase with enhanced carbohydrates
AMICUS THERAPEUTICS INC9 citations85
US11278601B2Mar 22, 2022
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC5 citations83
US10857212B2Dec 8, 2020
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC7 citations83
US10227577B2Mar 12, 2019
Method for selection of high M6P recombinant proteins
AMICUS THERAPEUTICS INC11 citations83
US10512676B2Dec 24, 2019
Formulations comprising recombinant acid alpha-glucosidase
AMICUS THERAPEUTICS INC14 citations82
US10874750B2Dec 29, 2020
Gene therapy constructs and methods of use
AMICUS THERAPEUTICS INC7 citations80
US11753632B2Sep 12, 2023
Highly potent acid alpha-glucosidase with enhanced carbohydrates
AMICUS THERAPEUTICS INC3 citations72
US11591583B2Feb 28, 2023
Highly potent acid alpha-glucosidase with enhanced carbohydrates
AMICUS THERAPEUTICS INC3 citations72
US11491211B2Nov 8, 2022
Formulations comprising recombinant acid alpha-glucosidase
AMICUS THERAPEUTICS INC3 citations69
US11491243B2Nov 8, 2022
Gene therapy constructs and methods of use
AMICUS THERAPEUTICS INC4 citations69
US12414985B2Sep 16, 2025
Augmented acid alpha-glucosidase for the treatment of Pompe disease
AMICUS THERAPEUTICS INC0 citations62
US11441138B2Sep 13, 2022
Method for selection of high M6P recombinant proteins
AMICUS THERAPEUTICS INC1 citations62
US11357834B2Jun 14, 2022
Recombinant α-galactosidase A for treatment of Fabry disease
AMICUS THERAPEUTICS INC1 citations62
US12246062B2Mar 11, 2025
Recombinant human acid alpha-glucosidase
AMICUS THERAPEUTICS INC1 citations60